CYP Inhibition Study of CDRI-Picroliv Using Human Liver Microsomes

This tender seeks proposals for a Non-GLP CYP Inhibition study of the AYUSH product CDRI-Picroliv. The study will encompass an analysis of inhibition against human liver microsomes for the following cytochrome P450 isoforms: CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. The work is to be completed within a period of 90 days from the award of the contract. The tender is issued by the Head, BDG, on behalf of the Council of Scientific and Industrial Research (CSIR) - Central Drug Research Institute (CDRI), Lucknow. Key dates for this limited tender include a document download start date of October 7, 2026, 01:05 PM, with the download end date set for October 28, 2026, 09:00 AM. Bid submission will commence on October 7, 2026, 01:30 PM, and conclude on October 28, 2026, 09:00 AM. The bid opening is scheduled for October 29, 2026, 10:00 AM at CSIR-CDRI, Lucknow. This is a two-cover tender, with Cover 1 for technical proposals and Cover 2 for financial proposals. The tender reference number is RFP/2026-27/BDG/80442. No tender fee or EMD is applicable for this procurement.